{"month_page_array":[{"month_page_keys":"https:\/\/lenz-tx.com\/","month_page_clicks":430,"month_page_impressions":4026},{"month_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","month_page_clicks":68,"month_page_impressions":1845},{"month_page_keys":"https:\/\/lenz-tx.com\/our-team\/","month_page_clicks":42,"month_page_impressions":1303},{"month_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","month_page_clicks":11,"month_page_impressions":243},{"month_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","month_page_clicks":11,"month_page_impressions":1473},{"month_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","month_page_clicks":4,"month_page_impressions":51},{"month_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","month_page_clicks":4,"month_page_impressions":138},{"month_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","month_page_clicks":3,"month_page_impressions":259},{"month_page_keys":"https:\/\/lenz-tx.com\/news\/","month_page_clicks":3,"month_page_impressions":144},{"month_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","month_page_clicks":2,"month_page_impressions":115}],"three_page_array":[{"three_page_keys":"https:\/\/lenz-tx.com\/","three_page_clicks":1081,"three_page_impressions":9654},{"three_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","three_page_clicks":165,"three_page_impressions":5064},{"three_page_keys":"https:\/\/lenz-tx.com\/our-team\/","three_page_clicks":111,"three_page_impressions":3861},{"three_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","three_page_clicks":29,"three_page_impressions":2986},{"three_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","three_page_clicks":28,"three_page_impressions":701},{"three_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","three_page_clicks":17,"three_page_impressions":442},{"three_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","three_page_clicks":8,"three_page_impressions":126},{"three_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","three_page_clicks":7,"three_page_impressions":1275},{"three_page_keys":"https:\/\/lenz-tx.com\/news\/","three_page_clicks":6,"three_page_impressions":353},{"three_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","three_page_clicks":5,"three_page_impressions":442}],"six_page_array":[{"six_page_keys":"https:\/\/lenz-tx.com\/","six_page_clicks":1851,"six_page_impressions":20883},{"six_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","six_page_clicks":290,"six_page_impressions":8886},{"six_page_keys":"https:\/\/lenz-tx.com\/our-team\/","six_page_clicks":165,"six_page_impressions":7238},{"six_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","six_page_clicks":60,"six_page_impressions":5641},{"six_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","six_page_clicks":35,"six_page_impressions":910},{"six_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","six_page_clicks":27,"six_page_impressions":1140},{"six_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","six_page_clicks":13,"six_page_impressions":1790},{"six_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","six_page_clicks":10,"six_page_impressions":1082},{"six_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","six_page_clicks":10,"six_page_impressions":274},{"six_page_keys":"https:\/\/lenz-tx.com\/news\/","six_page_clicks":7,"six_page_impressions":717}],"nine_page_array":[{"nine_page_keys":"https:\/\/lenz-tx.com\/","nine_page_clicks":2618,"nine_page_impressions":49551},{"nine_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","nine_page_clicks":346,"nine_page_impressions":11069},{"nine_page_keys":"https:\/\/lenz-tx.com\/our-team\/","nine_page_clicks":199,"nine_page_impressions":9924},{"nine_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","nine_page_clicks":79,"nine_page_impressions":8628},{"nine_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","nine_page_clicks":43,"nine_page_impressions":2081},{"nine_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","nine_page_clicks":35,"nine_page_impressions":910},{"nine_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","nine_page_clicks":22,"nine_page_impressions":2429},{"nine_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","nine_page_clicks":12,"nine_page_impressions":1624},{"nine_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","nine_page_clicks":10,"nine_page_impressions":277},{"nine_page_keys":"https:\/\/lenz-tx.com\/news\/","nine_page_clicks":8,"nine_page_impressions":1168}],"year_page_array":[{"year_page_keys":"https:\/\/lenz-tx.com\/","year_page_clicks":3432,"year_page_impressions":51620},{"year_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","year_page_clicks":372,"year_page_impressions":11803},{"year_page_keys":"https:\/\/lenz-tx.com\/our-team\/","year_page_clicks":225,"year_page_impressions":11118},{"year_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","year_page_clicks":95,"year_page_impressions":9267},{"year_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","year_page_clicks":63,"year_page_impressions":2601},{"year_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","year_page_clicks":35,"year_page_impressions":910},{"year_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","year_page_clicks":22,"year_page_impressions":2429},{"year_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","year_page_clicks":14,"year_page_impressions":1734},{"year_page_keys":"https:\/\/lenz-tx.com\/news\/","year_page_clicks":12,"year_page_impressions":1506},{"year_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","year_page_clicks":10,"year_page_impressions":277}],"two_year_page_array":[{"two_year_page_keys":"https:\/\/lenz-tx.com\/","two_year_page_clicks":3432,"two_year_page_impressions":51620},{"two_year_page_keys":"https:\/\/lenz-tx.com\/pipeline\/aceclidine\/","two_year_page_clicks":372,"two_year_page_impressions":11803},{"two_year_page_keys":"https:\/\/lenz-tx.com\/our-team\/","two_year_page_clicks":225,"two_year_page_impressions":11118},{"two_year_page_keys":"https:\/\/lenz-tx.com\/presbyopia\/","two_year_page_clicks":95,"two_year_page_impressions":9267},{"two_year_page_keys":"https:\/\/lenz-tx.com\/contact-us\/","two_year_page_clicks":63,"two_year_page_impressions":2601},{"two_year_page_keys":"https:\/\/lenz-tx.com\/2021\/12\/lnz101-lnz100-phase-3-timing\/","two_year_page_clicks":35,"two_year_page_impressions":910},{"two_year_page_keys":"https:\/\/lenz-tx.com\/2021\/08\/developing-a-treatment-for-presbyopia\/","two_year_page_clicks":22,"two_year_page_impressions":2429},{"two_year_page_keys":"https:\/\/lenz-tx.com\/2021\/06\/lenz_therapeutics_debuts_with_series_a\/","two_year_page_clicks":14,"two_year_page_impressions":1734},{"two_year_page_keys":"https:\/\/lenz-tx.com\/news\/","two_year_page_clicks":12,"two_year_page_impressions":1506},{"two_year_page_keys":"https:\/\/lenz-tx.com\/2021\/09\/lenz_therapeutics_ceo_interview\/","two_year_page_clicks":10,"two_year_page_impressions":277}]}